Ad-hoc | 2 August 2011 07:00
Fresenius SE & Co. KGaA / Key word(s): Half Year Results
02.08.2011 07:00
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Excellent sales and earnings growth − Fresenius raises earnings outlook
Group sales increased by 4% (6% in constant currency) to EUR8,004 million
(H1 2010: EUR7,686 million). Organic sales growth was 5%. Acquisitions
contributed a further 1%. Currency translation had a negative effect of 2%.
Group EBIT increased by 8% (11% in constant currency) to EUR1,207 million
(H1 2010: EUR1,121 million). The EBIT margin improved to 15.1% (H1 2010:
14.6%).
Group net income* increased by 20% (22% in constant currency) to EUR363
million (H1 2010: EUR302 million). Earnings per ordinary share increased by
20% to EUR2.23. Group net income** (including special items) reached EUR257
million or EUR1.58 per ordinary share.
Fresenius raises its earnings outlook for 2011. The company now expects
2011 net income* to increase by 15% to 18% in constant currency.
Previously, Fresenius expected net income* growth of 12% to 16% in constant
currency. Fresenius confirms its sales guidance of 7% to 8% in constant
currency.
* Net income attributable to Fresenius SE & Co. KGaA; adjusted for the
effects of mark-to-market accounting of the Mandatory Exchangeable Bonds
(MEB) and the Contingent Value Rights (CVR) related to the acquisition of
APP Pharmaceuticals. Both are non-cash items.
** Net income attributable to Fresenius SE & Co. KGaA
(Financial statements according to U.S. GAAP)
Fresenius SE & Co. KGaA,
represented by Fresenius Management SE,
Board of Management
Bad Homburg v.d.H., August 2, 2011
End of note
02.08.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany
Phone: +49 (0)6172 608-2485
Fax: +49 (0)6172 608-2488
E-mail: ir-fre@fresenius.com
Internet: www.fresenius.com
ISIN: DE0005785604
WKN: 578560
Indices: DAX
Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard),
München; Freiverkehr in Berlin, Hamburg, Hannover, Stuttgart;
Terminbörse EUREX
End of Announcement DGAP News-Service
---------------------------------------------------------------------------